Breaking News Instant updates and real-time market news.

2022-05-11 08:03:11 ABSI Absci $4.00 / -0.29 (-6.77%) 08:03 05/11/22 05/11 08:03 05/11/22 08:03	Absci sees adding at least eight new Active Programs for 2022 Absci reiterates its guidance to add at least eight new Active Programs for 2022, representing 60% year-over-year growth. Absci maintains its full year 2022 guidance of expecting a net decrease in cash, cash equivalents, and restricted cash of approximately $120M, which includes one-time, time-based disbursements totaling $10.5M from restricted cash associated with the Denovium and Totient acquisitions.	11 May 08 Jun 22 Jul

2022-05-11 08:03:11

ABSI

Absci

$4.00 / -0.29 (-6.77%)

08:03

05/11/22

05/11

08:03

05/11/22

08:03

Absci sees adding at least eight new Active Programs for 2022

Absci reiterates its guidance to add at least eight new Active Programs for 2022, representing 60% year-over-year growth. Absci maintains its full year 2022 guidance of expecting a net decrease in cash, cash equivalents, and restricted cash of approximately $120M, which includes one-time, time-based disbursements totaling $10.5M from restricted cash associated with the Denovium and Totient acquisitions.

11
May
08
Jun

22
Jul

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Takeda Pharmaceutical: FDA approves sBLA for expanded use of TAKHZYRO » 18:51 02/03/23 02/03 18:51 02/03/23 18:51 TAK Takeda Pharmaceutical $15.98 / +0.255 (+1.62%) Takeda announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events TAK Takeda Pharmaceutical $15.98 / +0.255 (+1.62%) 01/23/23 Hutchmed licenses fruquintinib to Takeda Pharmaceutical for up to $1.13B 01/18/23 Cryoport announces new strategic partnership with Syneos Health 01/09/23 Takeda Pharmaceutical, Arrowhead announce topline results from SEQUOIA study 01/05/23 Takeda Pharmaceutical reports 'favorable' results from Phase 3 TAK-755 trial TAK Takeda Pharmaceutical $15.98 / +0.255 (+1.62%) 01/03/23 Wells Fargo Ascendis Pharma price target raised to $177 from $169 at Wells Fargo 12/13/22 Piper Sandler Takeda deal has positive read through for Ventyx, says Piper 11/11/22 BTIG Poseida Therapeutics price target lowered to $14 from $20 at BTIG 10/05/22 H.C. Wainwright H.C. Wainwright has more confidence in Astria opportunity after KalVista news TAK Takeda Pharmaceutical $15.98 / +0.255 (+1.62%) 08/30/22 Takeda eyes global vaccine market following Qdenga approval, FT reports 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 02/24/23 Annual Meeting of AAAAI 2023 03/17/23 2023 AAD Annual Meeting
Hot Stocks	LGI Homes announced it closed 331 homes in January » 18:29 02/03/23 02/03 18:29 02/03/23 18:29 LGIH LGI Homes $121.77 / -2.525 (-2.03%) As of January 31, the… As of January 31, the company had 97 active selling communities. ShowHide Related Items >><< Company News Street Research Earnings Events LGIH LGI Homes $121.77 / -2.525 (-2.03%) 01/31/23 LGI Homes announces expansion in Fort Myers market with newest community 01/05/23 LGI Homes closes 504 homes in December 12/05/22 LGI Homes announces 412 home closings in November 11/03/22 LGI Homes reports 797 home closings in October LGIH LGI Homes $121.77 / -2.525 (-2.03%) 11/22/22 JPMorgan LGI Homes price target raised to $84 from $73 at JPMorgan 10/10/22 Wedbush LGI Homes price target lowered to $84 from $94 at Wedbush 08/03/22 JMP Securities LGI Homes price target lowered to $140 from $175 at JMP Securities 07/12/22 JPMorgan LGI Homes price target lowered to $77 from $85 at JPMorgan LGIH LGI Homes $121.77 / -2.525 (-2.03%) 11/01/22 LGI Homes reports Q3 EPS $3.85, consensus $3.50 02/21/23 LGI Homes - LGIH
Hot Stocks	Atento announces successful capital raise » 18:16 02/03/23 02/03 18:16 02/03/23 18:16 ATTO Atento $4.40 / -1 (-18.52%) Atento confirms that it… Atento confirms that it has secured its previously announced financing program. The additional capital raised will further strengthen Atento's balance sheet and liquidity position as management focuses on transforming the business. The fourth quarter has continued the positive trend by generating strong EBITDA margin growth, delivering the cash balance to close at $84M on December 31, 2022. ShowHide Related Items >><< Company News Street Research Earnings ATTO Atento $4.40 / -1 (-18.52%) 02/03/23 Atento falls -27.7% 01/13/23 Atento falls -16.3% 01/12/23 Atento rises 5.9% 12/30/22 Atento falls -6.5% ATTO Atento $4.40 / -1 (-18.52%) 08/15/22 Barrington Atento price target lowered to $15 from $32 at Barrington ATTO Atento $4.40 / -1 (-18.52%) 11/15/22 Atento reports Q3 EPS 10c, two estimates (17c) 08/03/22 Atento sees FY22 revenue growth flat, consensus $1.5B 08/03/22 Atento reports Q2 EPS (83c) vs ($1.05) last year
Hot Stocks	Sony delays 'The Last of Us Part I' PC port to March 28 » 18:07 02/03/23 02/03 18:07 02/03/23 18:07 SONY Sony $93.12 / -0.72 (-0.77%) Sony's Naughty Dog… Sony's Naughty Dog has delated the PC port of 2022 video game "The Last of Us Part I" to March 28 from March 3. The game, which is a remake of the 2013 game of the same name, originally launched in 2022 for PlayStation 5. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SONY Sony $93.12 / -0.72 (-0.77%) 02/02/23 Sony rolls out PS5 software beta Discord Voice Chat, VRR support for 1440p 02/02/23 Sony appoints CFO Hiroki Totoki as president, succeeding Kenichiro Yoshida 02/01/23 Sony's 'God of War Ragnarok' sells 11M units since November 2022 release 01/30/23 Sony says consumers should now have an 'easier time' finding PS5s at retailers SONY Sony $93.12 / -0.72 (-0.77%) 02/03/23 Cowen Sony price target raised to $118 from $102 at Cowen 11/02/22 Cowen Sony price target lowered to $102 from $144 at Cowen 10/13/22 Oppenheimer Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval 09/07/22 Goldman Sachs Sony resumed with a Neutral at Goldman Sachs SONY Sony $93.12 / -0.72 (-0.77%) 02/02/23 Sony raises FY net income view to Y870B from Y840B 02/02/23 Sony reports nine months EPS Y654.41 vs. Y622.03 last year 11/01/22 Sony raises FY revenue view to Y11.6T from Y11.5T 11/01/22 Sony reports Q2 revenue Y2.752T vs. Y2.369T last year SONY Sony $93.12 / -0.72 (-0.77%) 01/31/23 Sony tells GI.biz it has not cut PSVR2 output numbers 01/31/23 Sony halves Q1 PSVR2 headset shipment forecast, Bloomberg reports 01/30/23 Xbox, PlayStation, Nintendo to skip E3 2023, IGN reports 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says SONY Sony $93.12 / -0.72 (-0.77%) 01/31/23 What You Missed This Week in Video Games 01/29/23 Box Office Battle: ‘Avatar 2’ stays atop chart in seventh weekend 01/26/23 What You Missed On Wall Street On Thursday 01/25/23 #SocialStocks: Musk refutes veracity of WSJ story that he seeks $3B in funding SONY Sony $93.12 / -0.72 (-0.77%) 09/30/22 Largest borrow rate increases among liquid names
Periodicals	Elon Musk prevails in shareholder lawsuit over 2018 tweet, WSJ says » 18:03 02/03/23 02/03 18:03 02/03/23 18:03 TSLA Tesla $189.96 / +1.64 (+0.87%) A jury rejected… A jury rejected shareholder claims that Elon Musk violated federal securities law when he tweeted in 2018 about potentially taking Tesla private, The Wall Street Journal's Rebecca Elliott reports. The nine-person jury said the investors who brought the class-action case failed to prove that Musk hurt them by tweeting about a possible deal. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TSLA Tesla $189.96 / +1.64 (+0.87%) 01/31/23 Tesla sees capex of $6.0B-$8.0B in 2023 and $7B-9B in 2024 and 2025 01/31/23 Tesla asked for documents on driver assist systems by DOJ 01/25/23 Tesla extends afterhours gains, up over 5% at $152.45 01/25/23 Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023 TSLA Tesla $189.96 / +1.64 (+0.87%) 01/30/23 Bernstein Bernstein sees orders as 'most critical' to Tesla stock 01/30/23 Berenberg Tesla upgraded to Buy from Hold at Berenberg 01/26/23 Morgan Stanley Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley 01/26/23 Wedbush Tesla price target raised to $200 from $175 at Wedbush TSLA Tesla $189.96 / +1.64 (+0.87%) 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close TSLA Tesla $189.96 / +1.64 (+0.87%) 02/03/23 Tesla's sales of China-made EVs up 10% y/y in January, Reuters reports 02/01/23 Tesla to ramp up Shanghai production, Reuters reports 01/31/23 Tesla considering plant near new Mexico City airport, Reuters reports 01/30/23 Twitter starts applying for U.S. state licenses in payment master plan, FT says TSLA Tesla $189.96 / +1.64 (+0.87%) 02/02/23 What You Missed On Wall Street This Morning 01/31/23 What You Missed On Wall Street On Tuesday 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning TSLA Tesla $189.96 / +1.64 (+0.87%) 02/03/23 Early notable gainers among liquid option names on February 3rd 02/02/23 Notable open interest changes for February 2nd 02/01/23 Notable open interest changes for February 1st 01/31/23 Notable open interest changes for January 31st
Hot Stocks	ArrowMark Financial Corp. reports estimated NAV $20.79 as of December 31 » 17:46 02/03/23 02/03 17:46 02/03/23 17:46 BANX ArrowMark Financial Corp. $18.62 / +0.32 (+1.75%) This NAV reflects the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News BANX ArrowMark Financial Corp. $18.62 / +0.32 (+1.75%) 12/19/22 ArrowMark Financial Corp. reports estimated NAV $21.18 as of November 30 11/21/22 ArrowMark Financial Corp. reports estimated NAV $20.91 as of October 31 10/14/22 ArrowMark Financial Corp. reports estimated NAV $20.74 per share 09/13/22 ArrowMark Financial Corp. announces estimated NAV of $21.23 as of August 31
Hot Stocks	BMW invests EUR800M in Mexican production site for electric vehicles » 17:31 02/03/23 02/03 17:31 02/03/23 17:31 BMWYY BMW $34.97 / -0.54 (-1.52%) The BMW Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly BMWYY BMW $34.97 / -0.54 (-1.52%) 01/04/23 BMW says company doubled EV sales in 2022, targets BEVs at 15% of total in 2023 12/21/22 Solid Power expands joint development agreement with BMW 11/25/22 BMW to invest more than 2B euros in Hungarian plant as part of 'e-mobility' plan 10/19/22 BMW announces $1.7B investment to build electric vehicles in the U.S. BMWYY BMW $34.97 / -0.54 (-1.52%) 02/02/23 Kepler Cheuvreux BMW downgraded to Reduce from Hold at Kepler Cheuvreux 01/30/23 Berenberg BMW downgraded to Hold from Buy at Berenberg 01/25/23 Morgan Stanley BMW price target lowered to EUR 85 from EUR 90 at Morgan Stanley 01/13/23 JPMorgan BMW price target raised to EUR 95 from EUR 90 at JPMorgan BMWYY BMW $34.97 / -0.54 (-1.52%) 09/30/22 Tesla forecasting jump in Q4 output, growth through 2023, Reuters reports 08/17/22 China's EVE to become main EV battery supplier for BMW, Reuters says 08/16/22 BMW investigating fatal crash involving iX SUV, Bloomberg reports BMWYY BMW $34.97 / -0.54 (-1.52%) 12/21/22 What You Missed On Wall Street On Wednesday 08/16/22 What You Missed On Wall Street On Tuesday 08/16/22 What You Missed On Wall Street This Morning
Syndicate	Getaround files to sell 127.42M shares of common stock for holders 17:24 02/03/23 02/03 17:24 02/03/23 17:24 GETR Getaround / + ShowHide Related Items >><< Company News Street Research On The Fly Events GETR Getaround / + 02/02/23 Getaround announces restructuring plan, 10% workforce reduction 02/01/23 Getaround receives continued listing standard notice from NYSE 11/16/22 Getaround, InterPrivate II Acquisition report effectiveness of Form S-4 GETR Getaround / + 01/13/23 Wedbush Getaround initiated with an Outperform at Wedbush 12/29/22 Piper Sandler Getaround initiated with an Overweight at Piper Sandler GETR Getaround / + 12/29/22 What You Missed On Wall Street On Thursday 12/29/22 What You Missed On Wall Street This Morning 12/29/22 Fly Intel: Pre-market Movers 03/12/23 35th Annual Roth Conference
Syndicate	Kiora Pharmaceuticals files to sell 1.05M shares of common stock for holders 17:23 02/03/23 02/03 17:23 02/03/23 17:23 KPRX Kiora Pharmaceuticals $3.52 / + (+0.00%) ShowHide Related Items >><< Company News Street Research KPRX Kiora Pharmaceuticals $3.52 / + (+0.00%) 01/03/23 Kiora Pharmaceuticals completes enrollment in PCED study for KIO-201 10/18/22 Kiora Pharmaceuticals Inc trading resumes 10/18/22 Kiora Pharmaceuticals Inc trading halted, volatility trading pause 10/13/22 Kiora Pharmaceuticals regains Nasdaq listing compliance KPRX Kiora Pharmaceuticals $3.52 / + (+0.00%) 01/03/23 Ladenburg Kiora Pharmaceuticals completes enrollment in Phase 2 study, says Ladenburg 08/25/22 Ladenburg Ladenburg starts ophthalmic-focused Kiora with a Buy 08/25/22 Ladenburg Kiora Pharmaceuticals initiated with a Buy at Ladenburg 08/15/22 Maxim Kiora Pharmaceuticals downgraded to Hold from Buy at Maxim
Syndicate	Durect announces $10M registered direct offering of common stock, warrants » 17:21 02/03/23 02/03 17:21 02/03/23 17:21 DRRX Durect $6.44 / +0.125 (+1.98%) Durect announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DRRX Durect $6.44 / +0.125 (+1.98%) 11/28/22 Durect announces 1-for-10 reverse stock split 10/06/22 Durect achieves enrollment milestone in Phase 2b AHFIRM trial 09/26/22 Durect, Innocoll announce US launch of POSIMIR DRRX Durect $6.44 / +0.125 (+1.98%) 12/07/22 Oppenheimer Durect price target raised to $32 from $6 at Oppenheimer 12/06/22 H.C. Wainwright Durect target adjusted to $35 for stock split at H.C. Wainwright 03/08/22 H.C. Wainwright H.C. Wainwright keeps $6 target on Durect after Q4 results 03/04/22 H.C. Wainwright Durect CFO exit does not impact positive thesis, says H.C. Wainwright DRRX Durect $6.44 / +0.125 (+1.98%) 11/02/22 Durect reports Q3 EPS (1c), consensus (1c) 08/04/22 Durect reports Q2 EPS (5c), consensus (4c)

Syndicate	IO Biotech files $250M mixed securities shelf 17:21 02/03/23 02/03 17:21 02/03/23 17:21 IOBT IO Biotech $2.71 / -0.035 (-1.28%) ShowHide Related Items >><< Company News Street Research Earnings IOBT IO Biotech $2.71 / -0.035 (-1.28%) 01/23/23 IO Biotech appoints Smith as General Counsel, Chief Compliance Officer 01/09/23 IO Biotech provides business update 11/09/22 IO Biotech: Cash on hand expected to support operations through mid-2024 11/03/22 IO Biotech enters collaboration with Merck for IO101-IO103 IOBT IO Biotech $2.71 / -0.035 (-1.28%) 11/21/22 H.C. Wainwright IO Biotech initiated with a Buy at H.C. Wainwright IOBT IO Biotech $2.71 / -0.035 (-1.28%) 11/09/22 IO Biotech reports Q3 EPS (56c), consensus (67c) 08/11/22 IO Biotech reports Q2 EPS (64c), consensus (68c)
Conference/Events	Activision Blizzard management to meet virtually with Benchmark » 17:08 02/03/23 02/03 17:08 02/03/23 17:08 ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 09:04 Today Activision Blizzard to pay $35M in settlement with SEC over whistleblower rule 01/24/23 Microsoft sees Q3 productivity revenue $16.9B-$17.2B 01/19/23 Sony announces additional games coming to PlayStation VR2 01/17/23 U.S. video game consumer spending rose 2% y/y in December, says NPD ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 01/27/23 Wedbush Activision Blizzard assumed with an Outperform at Wedbush 12/22/22 Needham Netflix 2023 estimates cut at Needham 12/06/22 Edward Jones Activision Blizzard upgraded to Buy from Hold at Edward Jones 12/01/22 Wedbush Activision Blizzard added to Best Ideas List at Wedbush ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says 01/27/23 Xbox boss Spencer tells IGN 2022 'too light on games' for Xbox 01/26/23 Sony's Ryan met with EU's Vestager over Activision deal, Reuters says 01/25/23 FTC filed Microsoft-Activision suit to dissuade EU settlement, Bloomberg says ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 01/31/23 What You Missed This Week in Video Games 01/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 What You Missed On Wall Street On Thursday 01/24/23 What You Missed This Week in Video Games 02/09/23 Activision Blizzard ATVI Activision Blizzard $75.23 / -1.92 (-2.49%) 11:22 Today Downside put Buyer in Activision Blizzard 01/18/23 Unusually active option classes on open January 18th 01/13/23 Activision Blizzard put volume heavy and directionally bearish 12/13/22 Activision Blizzard put volume heavy and directionally bearish
Syndicate	Lilium files to sell 3.1M Class A ordinary shares for holders 17:08 02/03/23 02/03 17:08 02/03/23 17:08 LILM Lilium $1.37 / +0.045 (+3.40%) ShowHide Related Items >><< Company News Street Research Options LILM Lilium $1.37 / +0.045 (+3.40%) 01/31/23 Lilium joins forces with GKN Aerospace for Lilium Jet's EWIS 12/05/22 Lilium announces contract with eVolare 11/23/22 Lilium closes $119M capital raise to fund development of new electric aircraft 11/18/22 Lilium announces pricing of $119M capital raise LILM Lilium $1.37 / +0.045 (+3.40%) 12/07/22 Piper Sandler Lilium price target lowered to $7 from $9 at Piper Sandler 12/07/22 Barclays Lilium downgraded to Underweight from Equal Weight at Barclays 11/15/22 Barclays Lilium price target lowered to $2 from $5 at Barclays 08/30/22 Piper Sandler Lilium price target lowered to $10 from $15 at Piper Sandler LILM Lilium $1.37 / +0.045 (+3.40%) 11/22/22 Lilium NV options imply 20.9% move in share price post-earnings 11/16/22 Lilium NV options imply 21.0% move in share price post-earnings
Syndicate	Hempacco files to sell 4.73M shares of common stock » 17:06 02/03/23 02/03 17:06 02/03/23 17:06 HPCO Hempacco $1.05 / -0.11 (-9.48%) The company currently… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly HPCO Hempacco $1.05 / -0.11 (-9.48%) 11/28/22 Hempacco, High Sierra enter joint venture agreement 09/01/22 HPCO Stock trading resumes 09/01/22 HPCO Stock trading halted, volatility trading pause 30 Aug HPCO Hempacco $1.05 / -0.11 (-9.48%) 09/03/22 Opening Day: Shuttle Pharmaceuticals rockets higher in market debut
Hot Stocks	Forest Road Acquisition Corp. II, HyperloopTT terminate merger agreement » 17:02 02/03/23 02/03 17:02 02/03/23 17:02 FRXB Forest Road Acquisition Corp. II $10.13 / +0.03 (+0.30%) Hyperloop Transportation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Syndicate	SAB Biotherapeutics files to sell 7.36M shares of common stock for holders 17:02 02/03/23 02/03 17:02 02/03/23 17:02 SABS SAB Biotherapeutics / + ShowHide Related Items >><< Company News Street Research Earnings SABS SAB Biotherapeutics / + 01/18/23 SAB Biotherapeutics gets additional $8.2M in funding in closeout DoD contract 01/10/23 SAB Biotherapeutics concludes IND-enabling GLP toxicology study for SAB-142 01/09/23 SAB Biotherapeutics CMO to present on biologics in immunology 01/05/23 SAB Biotherapeutics announces results from project using DiversitAb platform SABS SAB Biotherapeutics / + 11/29/22 H.C. Wainwright SAB Biotherapeutics initiated with a Buy at H.C. Wainwright 08/11/22 Chardan SAB Biotherapeutics price target lowered to $3 from $7 at Chardan 08/11/22 Baird SAB Biotherapeutics price target lowered to $4 from $8 at Baird 05/13/22 Chardan SAB Biotherapeutics price target lowered to $7 from $10 at Chardan SABS SAB Biotherapeutics / + 11/15/22 SAB Biotherapeutics reports Q3 EPS (16c) vs (16c) last year 08/10/22 SAB Biotherapeutics reports Q2 EPS (11c) vs. (11c) last year
Hot Stocks	GAP Airports reports preliminary January passenger traffic up 33.1% » 17:01 02/03/23 02/03 17:01 02/03/23 17:01 PAC GAP Airports $180.51 / +0.375 (+0.21%) For January 2023, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events PAC GAP Airports $180.51 / +0.375 (+0.21%) 01/17/23 GAP Airports guides FY23 revenue up 12%-14% 01/04/23 GAP Airports reports December traffic up 18.8% y/y and up 18.6% vs. 2019 12/05/22 GAP Airports reports total November traffic up 22.4% from 2019 level 10/05/22 GAP Airports reports September traffic up 27.4% vs. 2019 levels PAC GAP Airports $180.51 / +0.375 (+0.21%) 10/20/22 Grupo Santander GAP Airports downgraded to Underperform from Neutral at Grupo Santander 08/25/22 HSBC GAP Airports upgraded to Buy from Hold at HSBC 08/08/22 JPMorgan GAP Airports upgraded to Neutral from Underweight at JPMorgan 05/03/22 JPMorgan GAP Airports downgraded to Underweight from Neutral at JPMorgan 02/22/23 GAP Airports - PAC
Conference/Events	Columbia Sportswear management to meet virtually with Seaport Global » 17:00 02/03/23 02/03 17:00 02/03/23 17:00 COLM Columbia Sportswear $93.60 / -2.49 (-2.59%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COLM Columbia Sportswear $93.60 / -2.49 (-2.59%) 09/22/22 Columbia Sportswear sets three-year financial targets ahead of investor meeting COLM Columbia Sportswear $93.60 / -2.49 (-2.59%) 06:37 Today Baird Columbia Sportswear price target raised to $97 from $92 at Baird 01/23/23 UBS Columbia Sportswear price target raised to $92 from $90 at UBS 09/29/22 Citi Citi cuts VF target, says reduced outlook still 'somewhat aggressive' 09/27/22 Cowen Columbia Sportswear price target raised to $86 from $85 at Cowen COLM Columbia Sportswear $93.60 / -2.49 (-2.59%) 02/02/23 Columbia Sportswear sees FY23 EPS $5.15-$5.55, consensus $5.59 02/02/23 Columbia Sportswear reports Q4 EPS $2.02, consensus $2.28 10/27/22 Columbia Sportswear backs FY22 EPS view of $5.00-$5.40, consensus $5.16 10/27/22 Columbia Sportswear reports Q3 EPS $1.80, consensus $1.67 COLM Columbia Sportswear $93.60 / -2.49 (-2.59%) 09/22/22 What You Missed On Wall Street This Morning 02/09/23 Columbia Sportswear
Conference/Events	Bread Financial management to meet virtually with Seaport Global » 16:59 02/03/23 02/03 16:59 02/03/23 16:59 BFH Bread Financial $42.78 / -1.22 (-2.77%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BFH Bread Financial $42.78 / -1.22 (-2.77%) 02/01/23 Credit card stocks down after CFPB proposes changes to late fee rules 02/01/23 CFPB proposes lowering excessive credit card late fee cap to $8 02/01/23 CFPB proposes rule to rein in excessive credit card late fees 02/01/23 Bread Financial falls -14.2% BFH Bread Financial $42.78 / -1.22 (-2.77%) 02/01/23 BTIG CFPB credit card late fee proposal 'more onerous than expected,' says BTIG 01/26/23 Stephens Stephens remains buyer of Bread Financial on weakness 01/05/23 Stephens Stephens raises 'most conservative' card company Bread Financial to Overweight 01/05/23 Stephens Bread Financial upgraded to Overweight from Equal Weight at Stephens BFH Bread Financial $42.78 / -1.22 (-2.77%) 01/26/23 Bread Financial reports Q4 EPS ($2.68) - ($2.97) , consensus ($2.97) 10/27/22 Bread Financial reports Q3 EPS $2.69, consensus $2.59 BFH Bread Financial $42.78 / -1.22 (-2.77%) 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 What You Missed On Wall Street This Morning 02/07/23 Bread Financial
Syndicate	Comera Life Sciences files to sell 7.22M shares of common stock for holders 16:57 02/03/23 02/03 16:57 02/03/23 16:57 CMRA Comera Life Sciences $1.34 / +0.01 (+0.75%) ShowHide Related Items >><< Company News Earnings CMRA Comera Life Sciences $1.34 / +0.01 (+0.75%) 11/09/22 Comera Life Sciences appoints McCourt as Chief Business Officer 10/18/22 Comera Life Sciences announces preclinical results from its SEQURUS-2 study 10/04/22 Comera Life Sciences expands Woburn operations 08/31/22 Comera Life Sciences enters up to $15M purchase agreement with Arena Business CMRA Comera Life Sciences $1.34 / +0.01 (+0.75%) 11/10/22 Comera Life Sciences reports Q3 EPS (20c) vs. ($6.34) last year

Syndicate	Travelzoo files to sell 3.41M shares of common stock for holders 16:54 02/03/23 02/03 16:54 02/03/23 16:54 TZOO Travelzoo $4.83 / -0.37 (-7.12%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly TZOO Travelzoo $4.83 / -0.37 (-7.12%) 11/25/22 Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital 10/26/22 Travelzoo expects substantially higher revenue and profitability in Q4 TZOO Travelzoo $4.83 / -0.37 (-7.12%) 11/28/22 Barrington Travelzoo downgraded to Market Perform from Outperform at Barrington 08/08/22 Ascendiant Travelzoo upgraded to Buy from Hold at Ascendiant 07/29/22 Barrington Travelzoo price target lowered to $10 from $12 at Barrington 03/18/22 Ascendiant Travelzoo downgraded to Hold from Buy at Ascendiant TZOO Travelzoo $4.83 / -0.37 (-7.12%) 12/16/22 Travelzoo sees Q4 revenue $18.5M, consensus $17.6M 10/26/22 Travelzoo reports Q3 EPS 6c, consensus 11c TZOO Travelzoo $4.83 / -0.37 (-7.12%) 01/09/23 Fly Insider: Travelzoo, Box among week's notable insider trades 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning 12/16/22 Fly Intel: Pre-market Movers
Hot Stocks	KVH Industries enters support agreement with Black Diamond Capital » 16:49 02/03/23 02/03 16:49 02/03/23 16:49 KVHI KVH Industries $10.01 / + (+0.00%) KVH Industries announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings KVHI KVH Industries $10.01 / + (+0.00%) 01/19/23 KVH Industries introduces KVH Managed Firewall, KVH Cloud Email 11/21/22 KVH Industries receives noncompliance notification from Nasdaq 10/25/22 U.S. Coast Guard selects KVH Industries for five-year connectivity contract 08/19/22 KVH Industries adopts limited duration stockholder rights plan KVHI KVH Industries $10.01 / + (+0.00%) 12/08/22 Raymond James KVH Industries downgraded to Market Perform from Strong Buy at Raymond James KVHI KVH Industries $10.01 / + (+0.00%) 12/06/22 KVH Industries reports Q3 non-GAAP EPS 7c, consensus 1c 08/09/22 KVH Industries reports Q2 EPS 4c, consensus (8c)
General news	Treasury Market Summary: » 16:40 02/03/23 02/03 16:40 02/03/23 16:40 $ECON Economic Data / + Treasury Market Summary:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals On The Fly $ECON Economic Data / + $ECON Economic Data / + 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says 01/22/23 Fed sets course for milder interest-rate rise next month, WSJ says 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says $ECON Economic Data / + 16:16 Today What You Missed On Wall Street On Friday 02/01/23 What You Missed On Wall Street On Wednesday 01/24/23 What You Missed On Wall Street On Tuesday 01/18/23 What You Missed On Wall Street On Wednesday
Syndicate	Vapotherm files $200M mixed securities shelf 16:39 02/03/23 02/03 16:39 02/03/23 16:39 VAPO Vapotherm $1.07 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VAPO Vapotherm $1.07 / + (+0.00%) 12/06/22 Vapotherm announces NYSE continued listing standard notice 10/03/22 Vapotherm receives NYSE continued listing standard notice VAPO Vapotherm $1.07 / + (+0.00%) 11/03/22 Piper Sandler Vapotherm price target lowered to $1 from $2 at Piper Sandler 10/03/22 Piper Sandler Vapotherm's latest debt amendment 'more consequential', says Piper Sandler 08/04/22 BTIG Vapotherm downgraded to Neutral from Buy at BTIG 08/04/22 William Blair Vapotherm downgraded to Market Perform from Outperform at William Blair VAPO Vapotherm $1.07 / + (+0.00%) 11/02/22 Vapotherm cuts FY22 revenue view $64M-$66M from $76M-$81M 11/02/22 Vapotherm reports Q3 EPS (98c), consensus (78c) VAPO Vapotherm $1.07 / + (+0.00%) 12/05/22 Fly Insider: Vapotherm, Applovin among week's notable insider trades 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference
Hot Stocks	RH says certain financial statements 'should no longer be relied upon' » 16:39 02/03/23 02/03 16:39 02/03/23 16:39 RH RH $343.41 / -3.65 (-1.05%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RH RH $343.41 / -3.65 (-1.05%) 16:37 Today RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%) 12/08/22 RH says Q3 gross margin contracted 50bps 12/08/22 RH to acquire Dmitriy & Co 12/08/22 RH CEO to exercise expiring options RH RH $343.41 / -3.65 (-1.05%) 01/11/23 BofA Arhaus price target raised to $16.50 from $12 at BofA 01/04/23 Guggenheim RH filing implies $400M of shares bought back in Q4-to-date, says Guggenheim 12/13/22 Needham Williams-Sonoma initiated with a Hold at Needham 12/12/22 Cowen RH price target lowered to $320 from $350 at Cowen RH RH $343.41 / -3.65 (-1.05%) 12/08/22 RH narrow FY22 revenue growth view to down 4.5% to down 3.5% 12/08/22 RH reports Q3 EPS $5.67, consensus $4.70 12/08/22 Notable companies reporting after market close 09/08/22 RH sees Q3 revenue down 18% to down 15% RH RH $343.41 / -3.65 (-1.05%) 12/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 What You Missed On Wall Street On Monday 12/12/22 What You Missed On Wall Street This Morning 12/09/22 What You Missed On Wall Street On Friday 02/07/23 Retail & Fitness/Hardlines 02/07/23 RH RH RH $343.41 / -3.65 (-1.05%) 12/08/22 Restoration Hardware options imply 7.8% move in share price post-earnings 10/24/22 Restoration Hardware put volume heavy and directionally bearish 09/08/22 Restoration Hardware options imply 7.3% move in share price post-earnings 09/06/22 Restoration Hardware call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Today at 10:00

CNBC Investing Club with Jim Cramer Government Event

webcast
2023-02-06 at 00:00

AHR Expo 2023 Conferences

Georgia World Congress Center, Atlanta, GA
AOS ...
2023-02-06 at 00:00

KeyBanc Hosted Company Meetings at AHR 2023 Expo Conferences

Atlanta, GA
2023-02-06 at 00:00

Global Pharmacovigilance & Risk Management Strategies Conference Conferences

Bethesda, MD
APLS ...
2023-02-06 at 00:00

Biotech Ski Summit Conferences

Park City, UT
SLP
2023-02-06 at 00:00

Simulations Plus Firm Sponsored Meetings

Salt Lake City, UT
AUB
2023-02-06 at 00:00

Atlantic Union Bankshares Firm Sponsored Meetings

California
PPG
2023-02-06 at 00:00

PPG Firm Sponsored Meetings

Boston, MA
2023-02-06 at 00:00

Emerging Biotechnology/Biopharma Industry Meetings

Denver, CO
IX
2023-02-06 at 03:30

Orix - IX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	VERA X VERA Vera Therapeutics Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LIFC Priced at: $7.00 14.286M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ALGM X ALGM Allegro MicroSystems Block Trade Managers: Credit Suisse Priced at: $38.00 4.98M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPCR X GPCR Structure Therapeutics IPO Managers: Jefferies, SVB Securities, Guggenheim & BMO Capital Priced at: $15.00 10.74M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDXH X MDXH MDxHealth Secondary Managers: Cowen & William Blair, BTIG, KBCS Priced at: $4.00 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ROIV X ROIV Roivant Sciences Secondary Managers: Goldman Sachs, SVB Securities, Cowen & Cantor Fitzgerald Priced at: $7.50 26.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVTX X AVTX Avalo Therapeutics Spot Secondary Managers: SVB Securities & RBC Capital Priced at: $3.98 3.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CLLS X CLLS Cellectis Spot Secondary Managers: Jefferies & Barclays Priced at: $2.50 8.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDBL X EDBL Edible Garden Spot Secondary Managers: Maxim & Joseph Gunnar Priced at: $6.30 1.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TWO X TWO Two Harbors Spot Secondary Managers: Goldman Sachs, JPMorgan & Citi, JMP Securities Priced at: $17.80 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	WULF X WULF TeraWulf Spot Secondary Managers: JonesResearch $1.03
Thurs	ASST X ASST Asset Entities IPO Managers: Boustead $5.00 1.5M Shares
Fri	No deals

View All Syndicate Announcements »

Absci sees adding at least eight new Active Programs for 2022

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access